FDA’s Approval Process of Controversial Alzheimer’s Drug Was ‘Rife With Irregularities’: Congressional Probe
A vial and packaging for the drug Aduhelm is shown on June 7, 2021. (Biogen via AP)
Biden Touts Reduction of 2023 Medicare Fees, Due Largely to Limiting of Alzheimer’s Drug
President Joe Biden holds up a piece of paper he says highlights a plan by Sen. Rick Scott (R-Fla.) while delivering remarks about lowering health care costs in the Rose…